Copyright © Philip M. Parker, INSEAD. Terms of Use.
| CYMBAL CLAMPING DEVICE
CYMBAL DAMPER
CYMBAL DISPLAY AND STORAGE RACK
CYMBAL FIXATION DEVICE
CYMBAL FIXTURE
CYMBAL FOR PERCUSSION MUSICAL INSTRUMENTS
CYMBAL HOLDER WITH VIBRATION DAMPING
CYMBAL PERFORMANCE SUPPORT AND CLAMP
CYMBAL POSITION CONTROL APPARATUS
CYMBAL SLEEVE
CYMBAL SYSTEM
CYMENOL PREPARATION BY DIRECT DEHYDROGENATION
CYNLINDRICAL BALE TRAILER
CYP2A6 GENE JUDGMENT METHODS
CYP2D FLUORESCENT ASSAY REAGENTS
CYP3A4 NFSE VARIANT AND METHODS OF USE THEREFORE
CYP7 PROMOTER-BINDING FACTORS
CYPROTERONE ACETATE THIOACETATE
CYPROTERONE THIOPIVALATE
CYROGENIC COOLING SYSTEM WITH ACTIVE VIBRATION CONTROL
CYROGENIC INERTIAL MICRO-ELECTRO-MECHANICAL SYSTEM (MEMS) DEVICE
CYROGENIC UPPER STAGE FOR REUSABLE LAUNCH VEHICLE
CYS-SER-VAL-THR-CYS-GLY SPECIFIC TUMOR CELL ADHESION RECEPTOR
CYSS
CYST PUNCTURE CATHETER ASSEMBLY
CYSTATIN B MUTANTS
CYSTEAMINE DERIVATIVES AND ANTIRHEUMATIC AGENTS CONTAINING CYSTEAMINE DERIVATIVES
CYSTEAMINE PERMAMENT WAVE COMPOSITION AND METHOD
CYSTEAMINE PERMANENT WAVE COMPOSITION AND METHOD
CYSTEIC MONOSUCCINIC ACID AND ITS SALTS
CYSTEINAMIDE--CONTAINING PERMANENT WAVE COMPOSITION AND METHOD
CYSTEINE (NPYS)-CONTAINING PEPTIDES AND USE THEREOF FOR INHIBITING PLATELET AGGREGATION
CYSTEINE ADDED VARIANTS OF INTERLEUKIN-3 AND CHEMICAL MODIFICATIONS THEREOF
CYSTEINE AND SERINE PROTEASE INHIBITORS CONTAINING D-AMINO ACID AT THE P2 POSITION, METHODS OF MAKING SAME, AND METHODS OF USING SAME
CYSTEINE DEPLETED IL-6 MUTEINS
CYSTEINE DERIVATIVES
CYSTEINE PROTEASE AND SERINE PROTEASE INHIBITORS
CYSTEINE PROTEASE DERIVED FROM PARASITIC HELMINTHS
CYSTEINE PROTEASE GENE DEFECTIVE BACULOVIRUS, PROCESS FOR ITS PRODUCTION, AND PROCESS FOR THE PRODUCTION OF ECONOMIC PROTEIN BY USING THE SAME
CYSTEINE PROTEASE INHIBITOR
CYSTEINE PROTEASE INHIBITORS
CYSTEINE PROTEASE INHIBITORS CONTAINING HETEROCYCLIC LEAVING GROUPS
CYSTEINE PROTEASE INHIBITORS EFFECTIVE FOR IN VIVO USE
CYSTEINE PROTEASE INHIBITORS FOR USE IN TREATMENT OF IGE MEDIATED ALLERGIC DISEASES
CYSTEINE PROTEINASE INHIBITORS AND INHIBITOR PRECURSORS
CYSTEINE PROTEINASES, PRODUCTION AND USE
CYSTEINE THIOL-PROTECTED PEPTIDES FOR USE IN IMMUNOASSAYS
CYSTEINE/GLYCINE RICH PEPTIDES
CYSTEINE-DEPLETED PEPTIDES RECOGNIZED BY A3-RESTRICTED CYTOTOXIC LYMPHOCYTES, AND USES THEREFOR
CYSTEINE-MODIFIED ACIDIC FIBROBLAST GROWTH FACTOR
CYSTEINE-MODIFIED ACIDIC FIBROBLAST GROWTH FACTOR AND METHODS OF USE
CYSTEINE-PEGYLATED PROTEINS
CYSTEINYL PROTEASE INHIBITORS
CYSTEINYL TRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS
CYSTEINYL TRNA SYNTHETASE FROM STREPTOCOCCUS PNEUMONIAE
CYSTEINYL TRNA SYNTHETASE POLYNUCLEOTIDES OF STREPTOCOCCUS
CYSTEINYL-TRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS
CYSTIC FIBROSIS GENE
CYSTIC FIBROSIS MEDICAMENTS
CYSTIC FIBROSIS MUTATION CLUSTER
CYSTIC FIBROSIS TESTER
CYSTIC FIBROSIS THERAPY
CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (CFTR) PROTEIN
CYSTIC FIBROSIS TREATMENT
CYSTINE DEPLETED GLYCOPROTEIN HORMONES
CYSTINE KNOT PROTEIN AND MATERIALS AND METHODS FOR MAKING IT
CYSTINE-SILICONE COPOLYMERS AND THEIR USE FOR TREATING KERATIN SUBSTRATES
CYSTOSCOPY SPLASH SHIELD
CYSTOSTOMY CATHETER BELT
CYTARABINE DERIVATIVES, THE PREPARATION AND USE THEREOF
CYTARABINE OCFOSFATE HARD CAPSULE
CYTHOHESIN-PH PEPTIDES THAT AFFECT THE ABILITY OF INTEGRINS TO ADHERE
CYTIDINE DEAMINASE CDNA AS A POSITIVE SELECTABLE MARKER FOR GENE TRANSFER, GENE THERAPY AND PROTEIN SYNTHESIS
CYTIDINE-CONTAINING AND CYTOSINE-CONTAINING COMPOUNDS AS TREATMENTS FOR STIMULANT EXPOSURE
CYTIKINE SIGNAL REGULATORS
CYTOANALYZER USING SEPARATE SENSING PORTIONS ON A DECTECTOR AND METHOD FOR ALIGNING THE SAME
CYTOCENTRIFUGATION DEVICE
CYTOCENTRIFUGATION DEVICE, APPARATUS, AND METHOD
CYTOCENTRIFUGE ROTOR FOR CYTOCENTRIFUGATION DEVICES
CYTOCHALASIN AND ISOINDOLINONE DERIVATIVES AS INHIBITORS OF ANGIOGENESIS
CYTOCHALASINS USEFUL IN PROVIDING PROTECTION AGAINST NERVE CELL INJURY ASSOCIATED WITH NEURODEGENERATIVE DISORDERS
CYTOCHROME B5 GENE AND PROTEIN OF CANDIDA TROPICALIS AND METHODS RELATING THERETO
CYTOCHROME BD TYPE QUINOL OXIDASE GENE OF BREVIBACTERIUM LACTOFERMENTUM
CYTOCHROME C AND POLYNUCLEOTIDES ENCODING CYTOCHROME C
CYTOCHROME C GENE DERIVED FROM HYDROGEN BACTERIUM
CYTOCHROME OXIDASE MUTATIONS AIDING DIAGNOSIS OF SPORADIC ALZHEIMER'S DISEASE
CYTOCHROME P-450 CONSTRUCTS AND METHOD OF PRODUCING HERBICIDE-RESISTANT TRANSGENIC PLANTS
CYTOCHROME P-450 ENZYMES
CYTOCHROME P-450 MONOOXYGENASES
CYTOCHROME P-450 REDUCTASE SCREEN FOR ERGOSTEROL BIOSYNTHESIS INHIBITORS
CYTOCHROME P450 ARACHIDONIC ACID EPOXYGENASE GENETIC MUTATION ASSOCIATED WITH HYPERTENSION
CYTOCHROME P450 ELECTROCHEMICAL SYSTEM
CYTOCHROME P450 ENZYMES AND RELATED COMPOUNDS AND METHODS
CYTOCHROME P450 GENE
CYTOCHROME P450 GENE HIGHLY EXPRESSED IN THE INCOMPATIBLE INTERACTION
CYTOCHROME P450 MONOOXYGENASE AND NADPH CYTOCHROME P450 OXIDOREDUCTASE GENES AND PROTEINS RELATED TO THE OMEGA HYDROXYLASE COMPLEX OF CANDIDA TROPICALIS AND METHODS RELATING THERETO
CYTOCHROME P450 MONOOXYGENASES
CYTOCHROME P450.SUB.LPR GENE AND ITS USES
CYTODIAGNOSTIC METHOD USING ALSTONINE AS A SELECTIVE MARKER, AND DIAGNOSTIC KIT CONTAINING MARKER
CYTOFECTIN DIMERS AND METHODS OF USE THEREOF
CYTOFUNNEL ARRANGEMENT
CYTOGENETIC CHAMBER
CYTOKINE AND BIOASSAY THEREFOR
CYTOKINE AND HEMOPOIETIC FACTOR ENDOGENOUS PRODUCTION ENHANCER AND METHODS OF USE THEREOF
CYTOKINE AND HORMONE CARRIERS FOR CONJUGATE VACCINES
CYTOKINE ANTAGONISTS
CYTOKINE ANTAGONISTS FOR THE TREATMENT OF LOCALIZED DISORDERS
CYTOKINE ANTAGONISTS FOR THE TREATMENT OF SENSORINEURAL HEARING LOSS
CYTOKINE DESIGNATED 4-1BB LIGAND ANTIBODIES AND HUMAN RECEPTOR THAT BINDS THERETO
CYTOKINE DESIGNATED 4-IBB LIGAND
CYTOKINE DESIGNATED ELK LIGAND
CYTOKINE DESIGNATED LERK-5
CYTOKINE DESIGNATED LERK-6
CYTOKINE FAMILY MEMBER EF-7
CYTOKINE INHIBITING IMIDAZOLE SUBSTITUTED HYDROXAMIC ACID DERIVATIVES
CYTOKINE INHIBITORS
CYTOKINE IP-10 AS AN ANTI-TUMOR AGENT
CYTOKINE POTENTIATOR AND PHARMACEUTICAL FORMULATION FOR CYTOKINE ADMINISTRATION
CYTOKINE PREPARATION FOR IMMUNOTHERAPY
CYTOKINE PRODUCTION AND TYROSINE KINASE INHIBITORS
CYTOKINE PRODUCTION INHIBITORS
CYTOKINE RECEPTOR AND NUCLEIC ACIDS ENCODING THE SAME
CYTOKINE RECEPTOR ZALPHA11
CYTOKINE REGULATED TRANSCRIPTION FACTOR
CYTOKINE REGULATORY AGENTS AND METHODS OF USE IN PATHOLOGIES AND CONDITIONS ASSOCIATED WITH ALTERED CYTOKINE LEVELS
CYTOKINE RELATED TO HEMOLYTIC ANEMIA AND METHOD OF USE
CYTOKINE RELATED TREATMENTS OF DISEASE
CYTOKINE RESTRAINING AGENTS
CYTOKINE RESTRAINING AGENTS AND METHODS OF USE IN PATHOLOGIES AND CONDITIONS ASSOCIATED WITH ALTERED CYTOKINE LEVELS
CYTOKINE SIGNAL REGULATORS
CYTOKINE SUPPRESSIVE ANIT-INFLAMMATORY DRUG BINDING PROTEINS
CYTOKINE SUPPRESSIVE ANTI-INFLAMMATORY DRUG BINDING PROTEIN
CYTOKINE SYNTHESIS INHIBITORY FACTOR (IL-10) AND PHARMACEUTICAL COMPOSITIONS THEREOF
CYTOKINE THAT BINDS ST2
CYTOKINE THAT INDUCES APOPTOSIS
CYTOKINE WHICH IS A LIGAND FOR OX40
CYTOKINE WHICH MEDIATES INFLAMMATION
CYTOKINE ZALPHA11 LIGAND
CYTOKINE ZALPHA11 LIGAND POLYNUCLEOTIDES
CYTOKINE-, STRESS-, AND ONCOPROTEIN-ACTIVATED HUMAN PROTEIN KINASE KINASES
CYTOKINE-FREE CULTURE OF DENDRITIC CELLS
CYTOKINE-INDUCED MARKER FOR INFLAMMATORY RESPONSE
CYTOKINE-INDUCED PROLIFERATION OF AMNIOTIC T-CELLS
CYTOKINE-LIKE PROTEINS THAT PROMOTE CELL PROLIFERATION
CYTOKINE-STRESS- AND ONCOPROTEIN-ACTIVATED HUMAN PROTEIN KINASE KINASES
CYTOKINES THAT BIND THE CELL SURFACE RECEPTOR HEK
CYTOKININ OXIDASE
CYTOLOGIC BRUSH FOR ENDOSCOPE
CYTOLOGIC METHOD OF EXAMINING MUCOUS MEMBRANES
CYTOLOGIC SAMPLING DEVICE FOR COLLECTING CERVICAL AND VAGINAL CELL SPECIMENS
CYTOLOGICAL AND HISTOLOGICAL FIXATURE COMPOSITION AND METHODS OF USE
CYTOLOGICAL EVALUATION OF BREAST DUCT EPITHELIAL CELLS RETRIEVED BY DUCTAL LAVAGE
CYTOLOGICAL FIXATIVE AND DEHYDRATING AGENT FOR TREATING HISTOLOGICAL AND CYTOLOGICAL TISSUE
CYTOLOGICAL IMAGING SYSTEM AND METHOD
CYTOLOGICAL SAMPLING METHOD AND DEVICE
CYTOLOGICAL SCREENING METHOD
CYTOLOGICAL SLIDE SCORING APPARATUS
CYTOLOGICAL SPECIMEN ANALYSIS SYSTEM WITH SLIDE MAPPING AND GENERATION OF VIEWING PATH INFORMATION
CYTOLOGICAL STAIN COMPOSITION
CYTOLOGICAL STAIN COMPOSITION INCLUDING VERIFICATION CHARACTERISTIC
CYTOLOGICAL SYSTEM AUTOFOCUS INTEGRITY CHECKING APPARATUS
CYTOLOGICAL SYSTEM ILLUMINATION INTEGRITY CHECKING APPARATUS AND METHOD
CYTOLOGICAL SYSTEM ILLUMINATION INTEGRITY CHECKING METHOD
CYTOLOGICAL SYSTEM IMAGE COLLECTION INTEGRITY CHECKING APPARATUS
CYTOLOGY CENTRIFUGE APPARATUS
CYTOLOGY CHAMBER WITH PORT TO RECEIVE COLLECTION BOTTLE AND METHOD OF USE
CYTOLOGY CHAMBER WITH SEPARATE LEG FOR FIXATIVE
CYTOLOGY COLLECTION DEVICE AND METHOD
CYTOLYSIN GENE AND GENE PRODUCT
CYTOLYTIC BRADYKININ ANTAGONISTS
CYTOLYTIC T CELL LINES WHICH BIND TO COMPLEXES OF TUMOR REJECTION ANTIGENS AND HLA-B44 MOLECULES
CYTOLYTIC T-CELL CLONES AGAINST COLORECTAL CARCINOMA
CYTOMEGALOVIRUS INHIBITING COMPOUNDS
CYTOMEGALOVIRUS PROTEINASE
CYTOMODULATING LIPOPHILIC PEPTIDES FOR MODULATING IMMUNE SYSTEM ACTIVITY AND INHIBITING INFLAMMATION
CYTOMODULATING PEPTIDE FOR INHIBITING LYMPHOCYTE ACTIVITY
CYTOPATHIC ADENOVIRAL E1B MUTATED VIRUSES FOR THERAPY AND PROPHYLAXIS OF NEOPLASIA
CYTOPATHIC REPLICATION OF HEPATITIS C VIRUS IN A NEW CELL LINE
CYTOPATHIC VIRUSES FOR THERAPY AND PROPHYLAXIS OF NEOPLASIA
CYTOPLASM FOR MAIZE
CYTOPLASMIC ANTIPROTEINASE-2 AND CODING SEQUENCES
CYTOPLASMIC ANTIPROTEINASE-2 AND CYTOPLASMIC ANTIPROTEINASE-3 AND CODING SEQUENCES
CYTOPLASMIC ANTIPROTEINASE-2 CODING SEQUENCES
CYTOPLASMIC BACTERIOPHAGE DISPLAY SYSTEM
CYTOPLASMIC EXPRESSION OF ANTIBODIES, ANTIBODY FRAGMENTS AND ANTIBODY FRAGMENT FUSION PROTEINS IN E. COLI
CYTOPLASMIC GENE INHIBITION OR GENE EXPRESSION IN TRANSFECTED PLANTS BY A TOBRAVIRAL VECTOR
CYTOPLASMIC INHIBITION OF GENE EXPRESSION
CYTOPLASMIC INHIBITION OF GENE EXPRESSION BY VIRAL RNA
CYTOPLASMIC INHIBITION OF GENE EXPRESSION IN A PLANT
CYTOPLASMIC MALE STERILE BRASSICA OLERACEA PLANT, AND METHOD FOR OBTAINING SUCH PLANT
CYTOPLASMIC MALE STERILE BRASSICA OLERACEA PLANTS WHICH CONTAIN THE POLIMA CMS CYTOPLASM AND ARE MALE STERILE AT HIGH AND LOW TEMPERATURES
CYTOPLASMIC MALE STERILE QUINOA
CYTOPLASMIC MALE STERILITY DNA FACTOR AND UTILIZATION THEREOF
CYTOPLASMIC MALE STERILITY SYSTEM PRODUCTION CANOLA HYBRIDS
CYTOPLASMIC MODULATORS OF INTEGRIN BINDING
CYTOPLASMIC MODULATORS OF INTEGRIN BINDING/SIGNALLING
CYTOPLASMIC MODULATORS OF INTEGRIN REGULATION/SIGNALING
CYTOPLASMIC-GENETIC MALE STERILE SOYBEAN AND METHOD FOR PRODUCING HYBRID SOYBEAN
CYTOPROTECTION UTILIZING ARYLTRIAZOL-3-THIONES
CYTOPROTECTIVE BENZOFURAN DERIVATIVES
CYTOPROTECTIVE BIOCOMPATIBLE CONTAINMENT SYSTEMS FOR BIOLOGICALLY ACTIVE MATERIALS AND METHODS OF MAKING SAME
CYTOPROTECTIVE COMPOUNDS
CYTOPROTECTIVE EFFECT OF POLYCYCLIC PHENOLIC COMPOUNDS
CYTOPROTECTIVE FATTY MOIETY COMPOUNDS
CYTOPROTECTIVE OLIGOSACCHARIDE FROM ALOE PREVENTING DAMAGE TO THE SKIN IMMUNE SYSTEM BY UV RADIATION
CYTOPROTECTIVE WOUND HEALING COMPOSITIONS AND METHODS FOR PREPARING AND USING SAME
CYTOPROTECTIVE, BIOCOMPATIBLE, RETRIEVABLE MACROCAPSULE CONTAINMENT SYSTEMS FOR BIOLOGICALLY ACTIVE MATERIALS
CYTORICH PROCESS SYSTEM
CYTOSCOPE DELIVERY SYSTEM
CYTOSINE DEAMINASE NEGATIVE SELECTION SYSTEM FOR GENE TRANSFER TECHNIQUES AND THERAPIES
CYTOSKELETAL ACTIVE AGENTS FOR GLAUCOMA THERAPY
CYTOSOLIC FORMS FOR .BETA.-LACTAMASE AND USES THEREOF
CYTOSOLIC FORMS OF BETA-LACTAMASE AND USES THEREOF
CYTOSOLIC PHOSPHOLIPASE A.SUB.2 -GAMMA ENZYMES AND POLYNUCLEOTIDES ENCODING SAME
CYTOSOLIC PHOSPHOLIPASE A2-BETA ENZYMES
CYTOSOLIC PHOSPHOLIPASE A2-GAMMA ENZYMES AND POLYNUCLEOTIDES ENCODING SAME
CYTOSTATIC AGENTS
CYTOSTATIC BETA-CARBOLINES
CYTOSTATIC OR CYTOTOXIC COMBINATION OF ACTIVE SUBSTANCES FOR USE IN THERAPEUTIC PROCEDURES
CYTOSTATIC PROCESS INCREASES THE PRODUCTIVITY OF CULTURED CELLS
CYTOSTATIN I
CYTOSTATIN II
CYTOSTATIN III
CYTOSTATIN III NUCLEIC ACIDS ENCODING
CYTOTACTIN DERIVATIVES THAT STIMULATE ATTACHMENT AND NEURITE OUTGROWTH, AND METHODS OF MAKING SAME
CYTOTOXIC AGENT AGAINST SPECIFIC VIRUS INFECTION
CYTOTOXIC AGENTS
CYTOTOXIC AGENTS BEARING A REACTIVE POLYETHYLENE GLYCOL MOIETY, CYTOTOXIC CONJUGATES COMPRISING POLYETHYLENE GLYCOL LINKING GROUPS, AND METHODS OF MAKING AND USING THE SAME
CYTOTOXIC AGENTS COMPRISING MAYTANSINOIDS AND THEIR THERAPEUTIC USE
CYTOTOXIC AGENTS COMPRISING MODIFIED DOXORUBICINS AND DAUNORUBICINS AND THEIR THERAPEUTIC USE
CYTOTOXIC AGENTS COMPRISING POLYETHYLENE GLYCOL-CONTAINING TAXANES AND THEIR THERAPEUTIC USE
CYTOTOXIC AGENTS COMPRISING TAXANES AND THEIR THERAPEUTIC USE
CYTOTOXIC ALKALOID DERIVATIVES INCLUDING ASMARINE A AND B ISOLATED FROM A SPONGE
CYTOTOXIC ALKALOIDS HALITULIN
CYTOTOXIC AND ANTIVIRAL COMPOUND
CYTOTOXIC ANTIBODY CONJUGATES OF HYDRAZIDE DERIVATIZED VINCA ANALOGS VIA SIMPLE ORGANIC LINKERS
CYTOTOXIC BICYCLO [7.3.1.]TRIDEC-4-ENE-2,6-DIYNE COMPOUNDS AND PROCESS FOR THE PREPARATION THEREOF
CYTOTOXIC BICYCLO[7.3.1]TRIDEC-4-ENE-2,6-DIYNE COMPOUNDS AND PROCESS FOR THE PREPARATION THEREOF
CYTOTOXIC BISPECIFIC MONOCLONAL ANTIBODY, ITS PRODUCTION AND USE
CYTOTOXIC BORONIC ACID PEPTIDE ANALOGS
CYTOTOXIC COMPOUNDS
CYTOTOXIC COMPOUNDS AND THEIR USE
CYTOTOXIC COMPOUNDS: DERIVATIVES OF THE PYRIDO[2,3,4-KL]ACRIDINE RING SYSTEM
CYTOTOXIC DIPHTHERIA TOXIN FRAGMENTS
CYTOTOXIC DRUG CONJUGATES
CYTOTOXIC DRUG CONJUGATES AND THEIR DELIVERY TO TUMOR CELLS
CYTOTOXIC DRUG CONJUGATES FOR TREATMENT OF NEOPLASTIC DISEASES
CYTOTOXIC DRUG THERAPY
CYTOTOXIC ENHANCEMENT OF TNF WITH COPPER | CYTOTOXIC FACTOR AS IS ASSOCIATED WITH MULTIPLE SCLEROSIS, ITS DETECTION AND ITS QUANTIFICATION
CYTOTOXIC MACROLIDES AND METHODS OF USE
CYTOTOXIC METABOLITES FROM MYRIAPORA TRUNCATA
CYTOTOXIC METAL CHELATORS AND METHODS FOR MAKING AND USING SAME
CYTOTOXIC PHARMACEUTICAL COMPOSITION
CYTOTOXIC PROTEIN FROM THE YEAST PICHIA INOSITOVORA
CYTOTOXIC PROTEIN FROM TRICHOSANTHES KIRILOWII
CYTOTOXIC PYRIDO[2,3,4-KI]ACRIDINE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE
CYTOTOXIC PYRIDOACRIDINE ALKALOIDS
CYTOTOXIC T LYMPHOCYTE ACTIVATION ASSAY
CYTOTOXIC T LYMPHOCYTE EPITOPES OF THE MAJOR OUTER MEMBRANE PROTEIN OF CHLAMYDIA TRACHOMATIS
CYTOTOXIC T LYMPHOCYTE-INDUCING LIPOPEPTIDES AND METHODS OF USE
CYTOTOXIC T LYMPHOCYTE-INDUCING LIPOPEPTIDES AND USE AS VACCINES
CYTOTOXIC T LYMPHOCYTE-MEDIATED IMMUNOTHERAPY
CYTOTOXIC T-ALL CELL LINES AND USES THEREFOR
CYTOTOXIC T-CELL EPITOPES
CYTOTOXIC T-CELL LYMPHOCYTE ("CTL") ACTIVITY REGULATION BY CLASS I MHC PEPTIDES
CYTOTOXIC T-LYMPHOCYTE ANTIGEN AS CYSTEINE PROTEASE INHIBITOR
CYTOTOXIC THERAPY FOR GRAFT REJECTION
CYTOTOXIC TRIS(OXAZOLE)-CONTAINING MACROLIDES
CYTOTOXICITY TEST METHOD
CYTOTOXICITY TESTING METHOD
CYTOTOXICITY-BASED GENETIC SELECTION SYSTEM (TOXSEL)
CYTOTOXIN (NON-NEUROTOXIN) FOR THE TREATMENT OF HUMAN HEADACHE DISORDERS AND INFLAMMATORY DISEASES
CYTOTRIENINS, PROCESS FOR PREPARING THE SAME AND ANTI-TUMOR AGENT
CYTOTROPHOBLAST ANTIGEN AND MONOCLONAL ANTIBODIES WHICH SPECIFICALLY BIND CYTOTROPHOBLAST CELLS
CYTOTROPIC HETEROGENEOUS MOLECULAR LIPIDS (CHML) AND PROCESS FOR PREPARING THE SAME |
|
Inventions Browse
Copyright © Philip M. Parker, INSEAD. Terms of Use.